Contribution of [

PET fluoroethyltyrosine (FET) glioma neuro-oncology nuclear medicine

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
18 Sep 2024
Historique:
received: 02 08 2024
revised: 14 09 2024
accepted: 15 09 2024
medline: 28 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

Gliomas, the most common type of primary malignant brain tumors in adults, pose significant challenges in diagnosis and management due to their heterogeneity and potential aggressiveness. This review evaluates the utility of O-(2-[

Identifiants

DOI: 10.3390/ph17091228 PMID: 39338390
pubmed: 39338390
pii: ph17091228
doi: 10.3390/ph17091228
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Auteurs

Jade Apolline Robert (JA)

CHU de Caen Normandie, UNICAEN, Department of Nuclear Medicine, Normandie Université, 14000 Caen, France.

Arthur Leclerc (A)

Department of Neurosurgery, Caen University Hospital, 14000 Caen, France.
Caen Normandie University, ISTCT UMR6030, GIP Cyceron, 14000 Caen, France.

Mathilde Ducloie (M)

Department of Neurology, Caen University Hospital, 14000 Caen, France.
Centre François Baclesse, Department of Neurology, 14000 Caen, France.
ORCID: 0009-0000-0034-9446

Evelyne Emery (E)

Department of Neurosurgery, Caen University Hospital, 14000 Caen, France.

Denis Agostini (D)

CHU de Caen Normandie, UNICAEN, Department of Nuclear Medicine, Normandie Université, 14000 Caen, France.

Jonathan Vigne (J)

CHU de Caen Normandie, UNICAEN, Department of Nuclear Medicine, Normandie Université, 14000 Caen, France.
CHU de Caen Normandie, UNICAEN Department of Pharmacy, Normandie Université, 14000 Caen, France.
Centre Cyceron, Institut Blood and Brain @ Caen-Normandie, Normandie Université, UNICAEN, INSERM U1237, PhIND, 14000 Caen, France.
ORCID: 0000-0002-6575-9224

Classifications MeSH